Weekly Update

Will The Needle Move For Medivation, Inc. (NASDAQ:MDVN) Shares This Earnings Season?

Wall Street is predicting that Medivation, Inc. (NASDAQ:MDVN)’s earnings per share (EPS) will be $N/A when the firm is expected to announce earnings around N/A. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each share[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For Zumiez Inc. (NASDAQ:ZUMZ) Shares This Earnings Season?

Wall Street is predicting that Zumiez Inc. (NASDAQ:ZUMZ)’s earnings per share (EPS) will be $0.64 when the firm is expected to announce earnings around 2017-03-09. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each share[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares This Earnings Season?

Wall Street is predicting that Sarepta Therapeutics, Inc. (NASDAQ:SRPT)’s earnings per share (EPS) will be $-1.26 when the firm is expected to announce earnings around 2017-02-23. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For Texas Roadhouse, Inc. (NASDAQ:TXRH) Shares This Earnings Season?

Wall Street is predicting that Texas Roadhouse, Inc. (NASDAQ:TXRH)’s earnings per share (EPS) will be $0.38 when the firm is expected to announce earnings around 2017-02-27. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For USA Technologies, Inc. (NASDAQ:USAT) Shares This Earnings Season?

Wall Street is predicting that USA Technologies, Inc. (NASDAQ:USAT)’s earnings per share (EPS) will be $-0.01 when the firm is expected to announce earnings around 2017-02-10. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For Luminex Corporation (NASDAQ:LMNX) Shares This Earnings Season?

Wall Street is predicting that Luminex Corporation (NASDAQ:LMNX)’s earnings per share (EPS) will be $0.12 when the firm is expected to announce earnings around 2017-02-06. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each share[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Shares This Earnings Season?

Wall Street is predicting that Cross Country Healthcare, Inc. (NASDAQ:CCRN)’s earnings per share (EPS) will be $0.21 when the firm is expected to announce earnings around 2017-03-08. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Shares This Earnings Season?

Wall Street is predicting that Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)’s earnings per share (EPS) will be $-0.45 when the firm is expected to announce earnings around 2017-03-06. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For China Biologic Products, Inc. (NASDAQ:CBPO) Shares This Earnings Season?

Wall Street is predicting that China Biologic Products, Inc. (NASDAQ:CBPO)’s earnings per share (EPS) will be $0.84 when the firm is expected to announce earnings around 2017-02-23. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to[Read More…]

by January 17, 2017 0 comments Weekly Update

Will The Needle Move For Vital Therapies, Inc. (NASDAQ:VTL) Shares This Earnings Season?

Wall Street is predicting that Vital Therapies, Inc. (NASDAQ:VTL)’s earnings per share (EPS) will be $-0.33 when the firm is expected to announce earnings around 2017-03-14. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by January 17, 2017 0 comments Weekly Update